Turning Point Therapeutics, Inc. (TPTX) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Cormorant Asset Management, LP mit 3,122,367 Aktien. Weitere bedeutende Anteilseigner sind GLAXOSMITHKLINE PLC und Cui Jingrong Jean.
TPTX Insider-Beteiligungen
Größter Aktionär
Cormorant Asset Management, LP
3,122,367 Aktien
Käufe (12 Monate)
0
$0.00 Wert
Verkäufe (12 Monate)
0
$0.00 Wert
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Cormorant Asset Management, Lp |
10 Percent Owner |
3,122,367 |
2019-05-16 |
|
| 2 |
Glaxosmithkline Plc |
Director |
2,253,660 |
2020-05-26 |
|
| 3 |
Cui Jingrong Jean |
Director |
540,383 |
2020-06-10 |
|
| 4 |
Johnson Craig A |
V.p. Finance, CFO & Secretary |
250,000 |
2009-02-05 |
|
| 5 |
Sun Brian |
SVP & General Counsel |
195,000 |
2022-04-12 |
|
| 6 |
Sabus Steve M |
SVP & Chief Commercial Officer |
165,000 |
2022-06-01 |
|
| 7 |
Countouriotis Athena |
President & CEO |
47,930 |
2022-02-11 |
|
| 8 |
Tombesi Paolo |
EVP & Chief Financial Officer |
28,700 |
2022-07-29 |
|
| 9 |
Partridge Andrew John |
EVP & Chief Commercial Officer |
22,078 |
2022-02-11 |
|
| 10 |
Bodem Barbara W. |
Director |
14,995 |
2021-04-01 |
|
| 11 |
Alta Partners Iii, Inc. |
Other: Former 10% Owner |
12,056 |
2009-09-08 |
|
| 12 |
Alta Partners |
Other: Former 10% Owner |
12,056 |
2009-09-08 |
|
| 13 |
North Annette |
EVP & General Counsel |
11,696 |
2022-02-11 |
|
| 14 |
Fisherman Jason S |
Director |
10,000 |
2008-06-23 |
|
| 15 |
Ratoff Steven B |
Director |
10,000 |
2008-06-23 |
|
| 16 |
Deleage Jean |
Director |
10,000 |
2008-06-20 |
|
| 17 |
Chacko Jacob |
Director |
8,500 |
2020-06-17 |
|
| 18 |
Gujrathi Sheila |
Director |
8,500 |
2020-06-17 |
|
| 19 |
George Simeon |
Director |
8,500 |
2021-06-04 |
|
| 20 |
Nicholson Garry A |
Director |
8,500 |
2021-06-04 |
|
Keine Beteiligungsdaten für TPTX verfügbar.
